PEA, Federico; PORRECA2, L2; BARALDO, Massimo; FURLANUT, Mario, High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2000, 45, pp. 329 - 335 [Scientific article]
Pea F.; Russo D.; Michieli M.; Baraldo M.; Ermacora A.; Damiani D.; Baccarani M.; Furlanut M., Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia, «CANCER CHEMOTHERAPY AND PHARMACOLOGY», 2000, 46, pp. 279 - 286 [Scientific article]
Ermacora, A; Michieli, M; Pea, F; Visani, G; Bucalossi, A; Russo, D, Liposome encapsulated daunorubicin (daunoxome) for acute leukemia, «HAEMATOLOGICA», 2000, 85, pp. 324 - 325 [Comment or similar]
PEA, Federico; POZ, Donatella; BARALDO, Massimo; FURLANUT, Mario, Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function. Multiple daily doses may be preferable, «CLINICAL DRUG INVESTIGATION», 2000, 19, pp. 213 - 218 [Comment or similar]
Pea F.; Furlanut M.; Bianchi L., Systemic vancomycin overexposure in a patient with spinal cord injury who had staphylococcal sepsis and Clostridium difficile colitis, «THERAPEUTIC DRUG MONITORING», 2000, 22, pp. 233 - 234 [Comment or similar]
Baraldo M.; Ferraccioli G.; Pea F.; Gremese E.; Furlanut M., Cyclosporine a pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy, «PHARMACOLOGICAL RESEARCH», 1999, 40, pp. 483 - 486 [Scientific article]
Pea F.; Milaneschi R.; Baraldo M.; Talmassons G.; Furlanut M., Isoniazid and its hydrazine metabolite in patients with tuberculosis, «CLINICAL DRUG INVESTIGATION», 1999, 17, pp. 145 - 154 [Scientific article]
Michieli M.; Damiani D.; Ermacora A.; Masolini P.; Michelutti A.; Michelutti T.; Russo D.; Pea F.; Baccarani M., Liposome-encapsulated daunorubicin for PGP-related multidrug resistance, «BRITISH JOURNAL OF HAEMATOLOGY», 1999, 106, pp. 92 - 99 [Scientific article]
Pea F.; Damiani D.; Michieli M.; Ermacora A.; Baraldo M.; Russo D.; Fanin R.; Baccarani M.; Furlanut M., Multidrug resistance modulation in vivo: The effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 1999, 55, pp. 361 - 368 [Scientific article]
Pea F.; Furlanut M.; Poz D.; Baraldo M., Pharmacokinetic profile of two different administration schemes of teicoplanin. Single 400 mg intravenous dose vs double-refracted 200 mg intramuscular doses in healthy volunteers, «CLINICAL DRUG INVESTIGATION», 1999, 18, pp. 47 - 55 [Scientific article]
Damiani D.; Michieli M.; Ermacora A.; Russo D.; Fanin R.; Zaja F.; Baraldo M.; Pea F.; Furlanut M.; Baccarani M., Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia, «LEUKEMIA», 1998, 12, pp. 1236 - 1240 [Scientific article]
Wu G.; Pea F.; Cossettini P.; Furlanut M., Effect of the number of samples on bayesian and non-linear least-squares individualization: A study of cyclosporin treatment of haematological patients with multidrug resistance, «JOURNAL OF PHARMACY AND PHARMACOLOGY», 1998, 50, pp. 343 - 349 [Scientific article]
Benetello P.; Furlanut M.; Fortunato M.; Pea F.; Baraldo M., Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association, «PHARMACOLOGICAL RESEARCH», 1997, 35, pp. 313 - 315 [Scientific article]
Benetello P.; Furlanut M.; Fortunato M.; Baraldo M.; Pea F.; Tognon A.; Testa G., Oral gabapentin disposition in patients with epilepsy after a high- protein meal, «EPILEPSIA», 1997, 38, pp. 1140 - 1142 [Scientific article]
Furlanut M.; Baraldo M.; Pea F.; Marzocchi V.; Croattino L.; Galla F., Blood concentrations and clinical effect of cyclosporin in psoriasis, «THERAPEUTIC DRUG MONITORING», 1996, 18, pp. 544 - 548 [Scientific article]
